BRIEF published on 07/26/2024 at 18:55, 3 months 25 days ago Merck KGaA Reports Strong Q2, Raises 2024 Guidance Healthcare Financial Forecast Q2 Results Merck KGaA Electronics
PRESS RELEASE published on 07/26/2024 at 18:50, 3 months 25 days ago EQS-Adhoc: Merck KGaA: Strong 2nd Quarter, Guidance raised Merck KGaA reports strong 2nd Quarter results, raises guidance for fiscal 2024, projecting higher net sales, EBITDA, and EPS. Healthcare and Electronics drive performance Healthcare Guidance Merck KGaA Electronics 2nd Quarter
BRIEF published on 06/24/2024 at 19:05, 4 months 26 days ago Merck KGaA Discontinues Phase III Trials of Xevinapant in Head & Neck Cancer Clinical Trials Head And Neck Cancer Merck KGaA Phase III Trials Xevinapant
PRESS RELEASE published on 06/24/2024 at 19:00, 4 months 26 days ago EQS-Adhoc: Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued Merck KGaA discontinues phase III trials of xevinapant in locally advanced head & neck cancer after interim analysis results. Xevinapant is currently under clinical investigation Merck KGaA Phase III Trials Xevinapant Locally Advanced Head & Neck Cancer Clinical Investigation
PRESS RELEASE published on 10/11/2023 at 22:06, 1 year 1 month ago EMD Electronics Celebrates Opening of New Arizona Factory, Contributing to the State's Growing Semiconductor Industry
PRESS RELEASE published on 05/30/2023 at 18:00, 1 year 5 months ago Merck KGaA, Darmstadt, Germany's New Barrier Materials Offer Superior Flexibility, Reliability, and Longer Lifetime in OLED Devices
PRESS RELEASE published on 05/15/2023 at 16:00, 1 year 6 months ago EMD Electronics Expands Renewable Energy Through Virtual Power Purchase Agreement With Recurrent Energy
PRESS RELEASE published on 04/12/2023 at 12:00, 1 year 7 months ago EMD Electronics Expands Semiconductor Manufacturing Capacities for the World's Largest Integrated Specialty Gases Facility in Hometown, Pennsylvania
Published on 11/21/2024 at 10:03, 27 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 30 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 30 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 55 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 5 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:04, 25 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 28 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 30 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 30 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 29 minutes ago Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 06:58, 3 hours 32 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 10 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 45 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 45 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
